- Home
- AEON vs CIF Comparison
AEON vs CIF Comparison
Compare AEON & CIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AEON | CIF |
|---|---|---|
| Founded | N/A | 1988 |
| Country | United States | United States |
| Employees | 8 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.8M | 29.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AEON | CIF |
|---|---|---|
| Price | $0.92 | $1.63 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.20 | N/A |
| AVG Volume (30 Days) | ★ 122.6K | 59.6K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.11% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.43 | $1.57 |
| 52 Week High | $1.45 | $1.82 |
Technical Indicators
Market Signals| Indicator | AEON | CIF |
|---|---|---|
| Relative Strength Index (RSI) | 42.62 | 45.18 |
| Support Level | $0.91 | N/A |
| Resistance Level | $1.12 | $1.73 |
| Average True Range (ATR) | 0.08 | 0.02 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 15.63 | 22.47 |
Price Performance
Historical ComparisonAbout AEON AEON Biopharma Inc.
AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.
About CIF MFS Intermediate High Income Fund
Mfs Intermediate High Income Fund is a United States-based diversified closed-end management investment company. Its investment objective is to seek high current income, but it may also consider capital appreciation. The fund invests a majority of its net assets, including borrowings for investment purposes, in high-income debt instruments. Its portfolio of investments includes investment-grade corporate bonds, government securities and other securities. The portfolio includes Midstream, Financial Institutions, Energy, Cable TV, and Utilities.